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Disseminated cutaneous nontuberculous mycobacteria infection is rare in immunocompetent hosts. We
report a case of Mycobacterium intracellulare infection in an immunocompetent patient presenting with
simultaneously developing multiple asymptomatic cutaneous papulonodules. The possibility of lung
lesions as the primary focus is suspected. We review the literature for other cases of multiple cutaneous
M avium complex infections in immunocompetent hosts. There are differences in the virulence of M
avium and M intracellulare, and hence in the underlying immune status of the hosts.
Copyright  2012, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Nontuberculous mycobacteria (NTM) are opportunistic pathogens
that can cause lung, skin/soft tissue, lymphatic, or disseminated
infections, mainly in immunocompromised patients. Mycobacte-
rium avium complex (MAC) consists of several closely related slow-
growing nonchromogens of NTMs, including M intracellulare. MAC
accounts for the largest portion of all NTM infections in most
epidemiologic series.1,2 They are environmental organisms widely
distributed in soil, water, and animals. The routes of infection
include inhalation, ingestion, or direct inoculation by trauma or
medical procedures. Disseminated NTM infections usually occur in
patients with acquired immunodeﬁciency syndrome (AIDS), and
they have been reported sporadically in patients with other forms
of immunosuppression. We report a rare case of disseminated
cutaneous MAC infection in an immunocompetent patient.
Case report
A man aged 54 years was referred to our clinic for slowly pro-
gressing asymptomatic eruptions. The lesions began ﬁrst on they, National Taiwan University
an. Tel.: þ886 2 23562141;
iwanese Dermatological Associatioright arm 2 years ago and additional lesions developed shortly after.
On inspection, erythematous indurated papules and nodules were
present on his right arm, left cheek, right ankle, and back (Figure 1).
None of the lesions showed surface changes of erosion, ulceration,
or desquamation. The skin biopsy in the referring hospital showed
granulomatous inﬂammation of the dermis and subcutis with
negative periodic acid-Schiff (PAS) and acid-fast stain for microor-
ganisms. The tissue cultures for bacteria, fungi, and mycobacteria
were all negative. Under the diagnosis of granuloma of unknown
causes, methotrexate and thalidomide were prescribed without
improvement.
The patient had been a truck driver dealing with waste recycling
formany years, but he did not recall any related trauma experiences
on the affected sites. He had a history of pulmonary tuberculosis
about 30 years ago, and he had received a complete antitubercu-
losis treatment course at that time. He was also a heavy smoker for
more than 30 years. One year before the ﬁrst presentation of his
right arm lesion, he had been hospitalized for 6 days due to atypical
pneumonia with fever, chills, dyspnea, weight loss, and hypo-
albuminemia. However, no speciﬁc pathogenwas identiﬁed during
the hospitalization. The clinical symptoms and pulmonary inﬁl-
trations improved after clarithromycin and amoxicillin/clavulanic
acid treatment, yet there were calciﬁed ﬁbronodular interstitial
inﬁltrates left in the left upper lobe of lung in the follow-up chest X-
ray. He was otherwise healthy and was not under anyn. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Discrete and conﬂuent red brown papulonodules on the face, limbs, and trunk.
Figure 2 Nodular inﬂammation involving the superﬁcial dermis and subcutis with
uninvolved epidermis.
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unremarkable.
We performed a skin biopsy from the right arm lesion that
showed noncaseating granulomatous inﬂammation involving
superﬁcial dermis and subcutis with scatteredmultinucleated giant
cells (Figures 2 and 3). The PAS and acid-fast stains were negative.
Two months later, the tissue culture grew a nontuberculous
mycobacterium. The isolate was negative for niacin accumulation,
catalase at 68C, hydrolysis of Tween 80, or arylsulfatase at 14 days.
The colonies of the isolates were buff after 14 days of incubation.
Conﬁrmation of these isolates to the species level was performed
by partial 16S rRNA gene (1464 bp) analysis using two primers
(primers 8FPL and 1492) as described previously.3 The sequences
were compared with known 16S rRNA gene sequences in the
GenBank database of the National Center for Biotechnology Infor-
mation using the basic local alignment search tool (BLAST) algo-
rithm. The species of all the isolates with the best match was M
intracellulare (accession number AY859027.1, 98% identity). No
lymphadenopathy was present, and the tests for human immuno-
deﬁciency virus (HIV) and antinuclear antibody were negative.
Serum protein electrophoresis revealed normal immunoglobulin
levels. After a 4-month treatment with oral clarithromycin 500 mg
twice daily and levoﬂoxacin 500mg daily, the lesions resolved with
residual hyperpigmentation (Figure 4). There was no recurrence of
the lesions 2 years after completion of the treatment. The follow-up
chest X-ray and computer tomography showed focal areas of
ﬁbroreticular shadows within the bilateral upper lungs consistent
with old tuberculosis.
Discussion
Disseminated NTM infections usually occur in patients with AIDS or
other forms of immunosuppression. The typical manifestations of
disseminated MAC infections are fever, night sweats, and weight
loss, with fever being the most common presentation.4Disseminated cutaneous MAC infections have an extremely rare
occurrence rate in immunocompetent patients, and most of the
reports are from Japan (Table 1).5e16 Concurrent non-cutaneous
foci, including lymph nodes, joints, bone marrow, or lung were
present in one-half of the cases (seven out of 14). Six out of the
seven cases with isolated cutaneous MAC infections had ulcers,
Figure 3 Noncaseating granulomatous inﬂammation with scattered multinucleated
giant cells.
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ment of multiple skin lesions may represent autoinoculation and
not true dissemination.13,14,16 Papulonodules without surface
changes, as seen in our patient, were present in four cases (Cases 1,
6e8). In three out of the four cases (Cases 1, 6e7), cervical
lymphadenopathy was also present.
Our patient had skin M intracellulare infections involving
different skin areas within a short period. In view of the simulta-
neous occurrence of multiple lesions and the absence of related
local skin trauma histories, we suspected that his skin infections
might result from a hematogenous or lymphatic spreading. The
atypical pneumonia one year before the skin eruptions might be
the source of his primary infection, which was partially controlled
by the antibiotics. In a study conducted by Reed and colleagues,17Figure 4 The papulonodular lesions resolved with residual hyperpigmentatiothe most signiﬁcant environmental risk factor for MAC infections
was cumulative occupational exposure to soil. The cumulative
exposure to recycled wastes, the prior pulmonary tuberculosis, and
the history of decades of smoking might contribute to the vulner-
ability to MAC pulmonary infection in our patient.18 The patho-
genesis of disseminated MAC infections in patients without
recognizable underlying immunosuppression is not well known.
Congenital or acquired defects in the interferon (IFN)-g/ interleukin
(IL)-12 pathways had been observed in some of these patients.19,20
Although in most literature, M avium and M intracellulare were
not differentiated due to their similar biochemical characteristics,
some epidemiologic studies implicated that these two organisms
exhibited different virulence. Most of the MAC infections in AIDS
patients were caused by M avium, whereas M intracellulare was
responsible for a larger portion of MAC lung diseases in non-HIV
patients.21 Moreover, among non-AIDS patients with MAC iso-
lated, only 16.2% of the patients with M avium had an American
Thoracic Society-deﬁned probable to deﬁnite infection, which is in
contrast with 63.1% of the M intracellulare group.22 An ecologic
study revealed that M intracellulare tended to form bioﬁlm more
often than M avium.23 This attachment and growth ability might
provide an explanation for the higher pathogenic property of M
intracellulare.
Currently, an established principle for treatment of MAC infec-
tions is a macrolide based two- or three-drug regimen for 6e12
months.18 In our case, because of the clinical resolution, the patient
refused further treatment after 4 months of clarithromycin and
levoﬂoxacin. No relapse was observed after a 2-year follow-up. As
the current MAC treatment guideline is mainly based on pulmonary
infection, whether a shorter course is acceptable for isolated
multiple cutaneous MAC infection remains unknown due to the
rarity of such cases. The prognosis varies widely and may be
affected by the underlying diseases, affected sites, and early
treatment.n after a 4-month treatment with oral clarithromycin and levoﬂoxacin.
Table 1 MAC infections in immunocompetent hosts with multiple cutaneous lesions.
Age/Sex Species Disease
duration
Involved skin areas Appearance of lesions Systemic involvement Treatment/response
1. 65/F5 MI 13 yr Back, face, neck, chest,
Rt forearm, loin
Violaceous and brown plaques Neck LAP DDS, INH, RFP 1 y/CR
2. 11/F6 MAC 3 yr Lt foot, Rt ankle, Rt hand,
Lt infraorbital
Subcutaneous plaques with
draining sinuses, crust
Osteomyelitis,
cervical LAP
NA
3. 20/M7 MAC 4 mo Face, Rt arm Violaceous edematous patch,
pustules, scar
Nil Clofazimine 6 mo,
then EB þ RFP 2 y/PR
4. 40/M7 MA 8 yr Face, upper back Eroded, crusted plaques Neck LAP, lung, INH, RFP, EB, clofazimine,
SM, 5 m/CR
5. 6/M8 MAC 1 mo Thighs, abdomen, Lt buttock,
Lt forearm
Nodules, ulcers Nil INH þ excision/CR
6. 62/F9 MAC 7 yr Face, ears, neck, abdomen, back Papules, nodules, plaques Cervical LAP CAM, ciproﬂoxacin, EB, 8 m/CR
7. 52/F9 MAC 3 yr Face, waist, back Pruritic papules and nodules Cervical LAP, bone
marrow, lung
SM, RFP, INH, EB, clofazimine/PR
8. 2/F10 MA 2 mo Lt axilla, Lt chest, Lt arm, Lt leg, Nodules Nil INH, RFP, cycloserine þ
excision/CR
9. 10/F11 MA 6 mo Back, Buttocks, thighs Nodules, ulcers, pus Inguinal LAP CAM, INH/PR
10. 48/M12 MA 31 yr
(skin 1 yr)
Lt shoulder, Rt thigh Scaly plaques Knee and ankle arthritis CAM, EB/CR
11. 11/F13 MA 1 yr Trunk, buttocks, thighs Nodules with discharge, ulcers,
hypertrophy scars
Nil CAM, 9 m/CR
12. yr9/F14 MA 4 mo Abdomen, hip, thighs Nodules, ulcers Nil Cycloserine, INH, CAM þ
excision/CR
13. 12/F15 MA 4 mo Buttocks, thighs Subcutaneous nodules with ﬁstula Nil Excision þ CAM/CR
14. 60/M16 MAC 10 yr Thighs, buttocks groin,
legs, abdomen
Erythematous squamous
patches with pustules
Nil TC þ ciproﬂoxacin, then CAM/PR
CAM ¼ clarithromycin; CR ¼ complete response; DDS ¼ dapsone; EB ¼ ethambutol; Ext ¼ external; F ¼ female; INH ¼ isoniazid; LAP ¼ lymphadenopathy; LN ¼ lymph node;
Lt ¼ left; M ¼ male; MA ¼ Mycobacterium avium; MAC ¼ Mycobacterium avium complex; MI ¼ Mycobacterium intracellulare; NA ¼ not available; PR ¼ partial response;
RFP ¼ rifampicin; Rt ¼ right; SM ¼ streptomycin; TC ¼ tetracycline; TMP/SMX ¼ trimethoprim-sulfamethoxazole.
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infection. It is interesting to note that most cases of disseminated
cutaneous MAC infection in immunocompetent hosts are reported
from Japan. However, it remains unknown whether this is due to
a report bias or there is a true racial or geographic difference. The
diagnosis of nonulcerated MAC infection without an identiﬁable
concurrent primary focus remains challenging anda correct diagnosis
is often delayed. More clinical vigilance is required for such cases.References
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